WENIG BEKANNTE FAKTEN üBER ARZNEIMITTELINFORMATIONEN.

While the US healthcare Anlage has come under fire for its lack of openness,[19] new legislation may encourage greater openness. There is a perceived tension between the need for transparency on the one hand and such issues as patient confidentiality and the possible exploitation of information for commercial gain on the other.Arzneimittel enthalte